ArticleJournal of microbiology and biotechnology2025
Establishment of High-Throughput Screening Protocol Based on Isomerase Using
Article in Journal of microbiology and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Directed evolution is a powerful tool in protein engineering that generates diverse variant libraries to enhance enzyme functionalities. However, the identification of desirable variants from large mutant libraries requires an efficient high-throughput screening (HTS) technique. In this study, we established a robust HTS protocol for selecting high-activity isomerase variants, specifically using L-rhamnose isomerase (L-RI) consistently; avoid switching between L-RI and L-RhI. L-RI catalyzes the isomerization of D-allulose to D-allose, which allows for activity detection via the reduction of the ketose D-allulose in a colorimetric assay based on Seliwanoff's reaction. Initial optimization was conducted in a single-tube format, where reaction conditions were refined and interfering factors were minimized. This optimized single-tube protocol demonstrated excellent accuracy when validated against high-performance liquid chromatography measurements, confirming its ability to precisely quantify D-allulose depletion. Subsequently, the protocol was successfully adapted to a 96-well plate format, incorporating further optimizations for protein expression and the removal of denatured enzymes. This involved methods such as cell harvest, supernatant removal, and filtration to reduce assay interference. The analytical quality of the established HTS protocol was evaluated using statistical metrics. The results yielded a Z'-factor of 0.449, a signal window (SW) of 5.288, and an assay variability ratio (AVR) of 0.551. All these values meet the acceptance criteria for high-quality of HTS assay. This HTS protocol is highly reliable and applicable for efficient screening of isomerase activity in various industrial and research areas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.